The viable myocardium: Epidemiology, detection, and clinical implications

Lancet

Volumn 351, Issue 9105, 1998, Pages 815-819

  Marwick, Thomas H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FIBRINOLYTIC AGENT;

CELL MEMBRANE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; EXERCISE; FIBRINOLYSIS; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; MORTALITY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; STUNNED HEART MUSCLE; SYMPTOM;

EID: 0032515776     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08080-X     Document Type: Review

References (24)

1. 1 Candell-Riera J, Permanyer-Miralda G, Castell J, et al. Uncomplicated first myocardial infarction: strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991; 18: 1207-19.
2. 2 Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-95.
3. 3 Yellon DM, Baxter GF, Marber MS. Angina reassessed: pain or protector? Lancet 1996; 347: 1159-62.
4. 4 Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 1982; 66: 1146-49.
5. 5 Schulz R, Heusch G. Characterization of hibernating and stunned myocardium. Eur Heart J 1995; 16: J19-25.
6. 6 Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 2113-15.
7. 7 Ross JJ. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation 1991; 83: 1076-83.
8. 8 Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-23.
9. 9 Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-88.
10. 10 Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-63.
11. 11 Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A.
12. 12 Hochberg MS, Parsonnet V, Gielchinsky I, Hussain SM. Coronary artery bypass grafting in patients with ejection fractions below forty percent: early and late results in 466 patients. J Thorac Cardiovasc Surg 1983; 86: 519-27.
13. 13 Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995; 92: 3593-612.
14. 14 Kaul S. There may be more to myocardial viability than meets the eye. Circulation 1995; 92: 2790-93.
15. 15 Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674-80.
16. 16 Schelbert HR. Blood flow and metabolism by PET. Cardiol Clin 1994; 12: 303-15.
17. 17 Hendel RC, Chaudhry FA, Bonow RO. Myocardial viability. Curr Probl Cardiol 1996; 21: 145-221.
18. 18 Vanoverschelde JL, Pasquet A, Melin JA. Echocardiographic techniques for assessment of myocardial viability. In: Marwick TH, ed. Cardiac stress testing and imaging. New York: Churchill Livingstone, 1996: 475-90.
19. 19 Kaul S. Response of dysfunctional myocardium to dobutamine. "The eyes see what the mind knows". J Am Coll Cardiol 1996; 27: 1608-11.
20. 20 Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992; 69: 854-59.
21. 21 Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-33.
22. 22 Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2687-94.
23. 23 Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132-39.
24. 24 Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.